CytomX Therapeutics (CTMX) Return on Capital Employed Growth (3y) (2018 - 2026)
CytomX Therapeutics (CTMX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | CytomX Therapeutics | 582.34 Mn | 235.63 Mn | - | 4,844.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,844.00 |
| Dec 31, 2025 | 9,060.00 |
| Sep 30, 2025 | 12,442.00 |
| Jun 30, 2025 | 11,387.00 |
| Mar 31, 2025 | 11,467.00 |
| Dec 31, 2024 | 9,865.00 |
| Sep 30, 2024 | 5,541.00 |
| Jun 30, 2024 | 4,743.00 |
| Mar 31, 2024 | 5,193.00 |
| Dec 31, 2023 | 1,528.00 |
| Sep 30, 2023 | 2,089.00 |
| Jun 30, 2023 | -2,093.00 |
| Mar 31, 2023 | -3,156.00 |
| Dec 31, 2022 | -5,911.00 |
| Sep 30, 2022 | -7,416.00 |
| Jun 30, 2022 | -4,171.00 |
| Mar 31, 2022 | -3,182.00 |
| Dec 31, 2021 | -2,089.00 |
| Sep 30, 2021 | -1,743.00 |
| Jun 30, 2021 | -1,374.00 |